FERACCRU

This brand name is authorized in Austria, Croatia, Estonia, Finland, Ireland, Lithuania, Poland, UK.

Active ingredients

The drug FERACCRU contains one active pharmaceutical ingredient (API):

1	Iron(III)-maltol UNII MA10QYF1Z0 - FERRIC MALTOL
	Iron in a stable ferric state as a complex with a trimaltol ligand. The complex is designed to provide, in a controlled way, utilisable iron for uptake across the intestinal wall and transfer to the iron transport and storage proteins in the body (transferrin and ferritin, respectively). The complex dissociates on uptake from the gastro-intestinal tract and the complex itself does not enter the systemic circulation.
	Read more about Ferric maltol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FERACCRU Capsules, hard	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03AB10		B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AB Iron trivalent, oral preparations
Discover more medicines within B03AB10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1713428
FI	Lääkealan turvallisuus- ja kehittämiskeskus	076534
GB	Medicines & Healthcare Products Regulatory Agency	325766
LT	Valstybinė vaistų kontrolės tarnyba	1079688, 1093328
PL	Rejestru Produktów Leczniczych	100366838